Market Overview - November begins with stock futures higher, following a successful October driven by artificial intelligence momentum [1] - The S&P 500 rose 2.3%, Dow Jones Industrial Average increased by 2.5%, and Nasdaq Composite jumped 4.7% in October [4] Berkshire Hathaway - Berkshire Hathaway's cash reserves reached a record high of $381.6 billion, surpassing the previous record of $347.7 billion [2] - The company reported a 34% increase in operating profit to $13.485 billion in Q3, with overall earnings rising 17% year over year to $30.8 billion [3] Big Tech Earnings - Major tech companies, including Meta, Amazon, Alphabet, and Microsoft, reported strong digital advertising sales, indicating resilience in ad budgets despite economic uncertainty [4] - The collective capital expenditure for the four tech giants is expected to exceed $380 billion this year, reflecting ongoing investment in AI [5] SNAP Benefits - A federal judge mandated that the Trump administration must utilize emergency funds to continue SNAP food benefits during the government shutdown, affecting 42 million Americans [6][7] Pharmaceutical Market - Eli Lilly and Novo Nordisk dominate the weight loss and diabetes drug market, which could reach $100 billion by 2030 [10] - Both companies are focusing on increasing supply and convenience while testing new uses for their drugs to fend off competition [11]